维普期刊资源整合服务平台（V6.5）

42篇 您的检索式：作者名="Vlerken"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Muhi-functional polymeric nanoparti- cles for tumour-targeted drug delivery 显示文摘	van Vlerken LE Amiji MM	2006	Expert Opin Drug Deliv2006，3，2：	1
2	Multi-functional polymeric nanoparticles for tumour-targeted drug delivery 显示文摘	van Vlerken LE Amiji MM	2006	Exp Opin Drug Del2006，3，2：	1
3	Chances for biological tech niques in sediment remediation 显示文摘	Marijke M A Ferdinandy - van Vlerken	1998	Wat Sci Tech1998，37，67：	1
4	Modulation of intracellular ceramide using polymeric nanoparticles to o- vercome muhidrug resistance in cancer 显示文摘	van Vlerken LE Duan Z Selden MV	2007	Cancer Res2007，67，10：	1
5	Patient adherence to antiviral treatment for chronic hepatitis B and C:a systematic review显示文摘	LIEVELD FI VAN VLERKEN LG SIEREMA PD	2013	Ann Hepatol2013，12，3：	1
6	E- valuations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formu- lations to overcome multidrug resistance in cancer cells 显示文摘	YADAV S VAN VLERKEN L E LITTLE S R	2009	Cancer Chemother Pharmacol2009，63，4：	1
7	Poly (ethylene glycol)- modified nanocarriers for tumor-targeted and intracellular delivery 显示文摘	von Vlerken L E Vyas T K Amiji M M	2007	Pharm Res2007，24，8：	1
8	Modulation of Intracellular Ceramide Using Polymeric Nanoparti-cles to Overcome Multidrug Resistance in Cancer显示文摘	Lilian E. van Vlerken Zhenfeng Duan Michael V. Seiden		0，，：	1
9	Poly ( ethylene glycol ) - modified nanocarriers for tumor-targeted and intracellular delivery 显示文摘	van Vlerken LE Vyas TK Amiji MM	2007	Pharm Res2007，24，8：	1
10	Multi-functional nanocarriers to overcome tumor drug resistance显示文摘	Jabr-Milane LS van Vlerken LE Yadav S	2008	Cancer Treat Rev2008，34，7：	1
11	Multi-functional nanocarriers to overcome tumor drug resistance 显示文摘	Jabr-Milane L S van Vlerken Yadav S	2008	Cancer Treat Rev2008，34，7：	1
12	EZH2 is required for breast and pancreatic cancer stem cell ma- intenance and can be used as a functional cancer stem cell re- porter 显示文摘	VAN VLERKEN LE KIEFER CM MOREHOUSE C	2013	Stem Cells Transl Med2013，2，1：	1
13	Multi - functional nanocarriers to overcome tumor drug resistance 显示文摘	Jabr - Milane LS Van Vlerken LE Yadav S	2008	Cancer Treat Rev2008，34，7：	1
14	Poly(ethylene glycol)-modifled nanocarriers for tumor-targeted and intracellular delivery 显示文摘	van Vlerken LE Vyas TK Amiji MM	2007	Pharm Res2007，24，8：	1
15	Multi-functional nanocarriers to overcome tumor drug resistance显示文摘	Lara S. Jabr-Milane Lilian E. van Vlerken Sunita Yadav Mansoor M. Amiji	2008	Cancer Treatment Reviews2008，，7：	1
16	The role of epigenetic regulation in stem cell and cancer biology 显示文摘	V AN VLERKEN L E HURT E M HOLLINGSWORTH R E	2012	J Mol Med2012，90，7：	1
17	EZH2 is required for breast and pancreatic cancer stem cell maintenance and can be used as a functional cancer stem cell reporter 显示文摘	VAN VLERKEN L E KIEFER C M MOREHOUSE C	2013	Stem Cells Trans Med2013，2，1：	1
18	Modulation of intracellular ceramide using poly- meric nanoparticles to overcome multidrug resistance in cancer 显示文摘	Van VLERKEN L E DUAN Z SEIDEN M V	2007	Cancer Res2007，67，10：	1
19	EZH2 is required for breast and pancreatic cancer stem cell maintenance and can be used as a functional cancer stem cell reporter显示文摘	van Vlerken LE Kiefer CM Morehouse C	2013	Stem Cells Transl Med2013，2，1：	1
20	Augmentation of therapeutic efficacy in drug-resistant tumor models u- sing ceramide coadministration in temporal-controlled polymer-blend nanoparticle delivery systems 显示文摘	van Vlerken LE Duan Z Little SR	2010	AAPS J2010，12，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示